The Use of TachoSil in Children Undergoing Liver Resection With or Without Segmental Liver Transplantation

Abstract

Introduction: Local haemostatic agents are used for the control of surgical haemorrhage when standard techniques are inadequate, but there are few studies of these products in children.

Patients and Methods: This was a prospective, open-label study in which children (aged 4 weeks to 6 years) undergoing liver resection with or without segmental liver transplantation were treated with TachoSil, a collagen patch coated with a dry layer of human fibrinogen and human thrombin, if minor (i. e., oozing) or moderate bleeding was present after primary haemostatic treatment. Time to haemostasis after TachoSil application was the primary endpoint. Safety was assessed by adverse events (AEs), including post-operative infections, symptoms of graft rejection and re-operations.

Results: Enrolment was stopped early after 16 children had entered the study. 13 children underwent whole liver resection and transplantation and 3 patients underwent segmental resection. Satisfactory haemostasis was achieved in 13 children (81.3%; 95% CI: 61.8–100%) at 3 min and in 1 child at 8 min. Occurrence of AEs was as expected, with most being known complications of the underlying disease, surgical procedure, or use of immunosuppressive medication. No AEs were considered to be related to the use of TachoSil.

Conclusions: The use of TachoSil for haemostasis after primary haemostatic treatment appears to be safe and effective in children undergoing liver resection.

Key words

haemostasis - surgical - liver transplantation - TachoSil

References

• 1 Deshpande RR, Bowles MJ, Vilca-Melendez H. et al . Results of split liver transplantation in children.  Ann Surg. 2002;  236 248-253
• 2 De Boer MT, Molenaar IQ, Hendriks HG. et al . Minimizing blood loss in liver transplantation: progress through research and evolution of techniques.  Dig Surg. 2005;  22 265-275
• 3 Berrevoet F, De Hemptinne B. Use of topical hemostatic agents during liver resection.  Dig Surg. 2007;  24 288-293
• 4 Frilling A, Stavrou GA, Mischinger HJ. et al . Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial.  Langenbecks Arch Surg. 2005;  390 114-120
• 5 Fischer L, Seiler CM, Broelsch CE. et al . Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: An open, randomized, prospective, multicenter, parallel-group trial.  Surgery. 2010;  DOI: doi:10.1016/j.surg.2010.02.008
• 6 Siemer S, Lahme S, Altziebler S. et al . Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study.  Eur Urol. 2007;  52 1156-1163
• 7 Maisano F, Kjaergård HK, Bauernschmitt R. et al . TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial.  Eur J Cardiothorac Surg. 2009;  36 708-714
• 8 Andrew M, Paes B, Milner R. et al . Development of the human coagulation system in the full-term infant.  Blood. 1987;  70 165-172
• 9 García S, Roque J, Ruza F. et al . Infection and associated risk factors in the immediate postoperative period of pediatric liver transplantation: a study of 176 transplants.  Clin Transplant. 1998;  12 190-197
• 10 Colombani PM, Lau H, Prabhakaran K. et al . Cumulative experience with pediatric living related liver transplantation.  J Pediatr Surg. 2000;  35 9-12
• 11 Bouchut JC, Stamm D, Boillot O. et al . Postoperative infectious complications in paediatric liver transplantation: a study of 48 transplants.  Paediatr Anaesth. 2001;  11 93-98
• 12 Wilde J, Chin S, Johnston P. et al . Paediatric liver transplantation in New Zealand: the first 5 years.  N Z Med J. 2007;  120 U2679
• 13 D’Alessandro AM, Knechtle SJ, Chin LT. et al . Liver transplantation in pediatric patients: twenty years of experience at the University of Wisconsin.  Pediatr Transplant. 2007;  11 661-670
• 14 Shepherd RW, Turmelle Y, Nadler M. et al . Risk factors for rejection and infection in pediatric liver transplantation.  Am J Transplant. 2008;  8 396-403
• 15 Wagner C, Beebe DS, Carr RJ. et al . Living related liver transplantation in infants and children: report of anaesthetic care and early postoperative morbidity and mortality.  J Clin Anesthesia. 2000;  12 454-459
• 16 Lacanna F, Brunati A, Reding R. A new biological mesh for cut surface hemostasis in liver transplantation using technical variants.  Pediatr Transplant. 2008;  12 520-521
• 17 Carbon RT, Baar S, Waldschmidt J. et al . Innovative minimally invasive pediatric surgery is of therapeutic value for splenic injury.  J Pediatr Surg. 2002;  37 1146-1150
• 18 Carbon RT, Reingruber B, Baar S. et al .Innovative surgical management of NEC – results of 52 consecutive cases.. In: Faist E, editor. 7th World Congress on Trauma, Shock, Inflammation and Sepsis, Munich, March 13–17, 2007 Medimond International Proceedings, Bologna, Italy; 2007a
• 19 Carbon RT, Reingruber B, Hümmer HP. et al .Fast-track surgery of recurrent pneumothorax in patients with cystic fibrosis – superiority of minimally invasive tissue management.. In: Faist E, editor. 7th World Congress on Trauma, Shock, Inflammation and Sepsis, Munich, March 13–17, 2007 Medimond International Proceedings, Bologna, Italy; 2007b
• 20 Haas S. The use of a surgical patch coated with human coagulation factors in surgical routine: a multicenter postauthorization surveillance.  Clin Appl Thromb Hemost. 2006;  12 445-450
• 21 Birth M, Figueras J, Bernardini S. et al . Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study.  Patient Saf Surg. 2009;  3 13
• 22 Stark J, De Leval M. Experience with fibrin seal (Tisseel) in operations for congenital heart defects.  Ann Thorac Surg. 1984;  38 411-413
• 23 Tokunaga Y, Tanaka K, Uemoto S. et al . Fibrin sealant of the cut surface of partial liver grafts from living donors.  J Invest Surg. 1995;  8 243-251
• 24 Codispoti M, Mankad PS. Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised controlled trial.  Eur J Cardiothorac Surg. 2002;  22 200-205

Correspondence